Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director

AEOLUS PHARMACEUTICALS, INC. (AOLS) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/22/2017 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
08/14/2017 10-Q Quarterly Report for the period ended June 30, 2017
05/15/2017 10-Q Quarterly Report for the period ended March 31, 2017
03/24/2017 8-K Quarterly results
02/17/2017 10-Q Quarterly Report for the period ended December 31, 2016
02/14/2017 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
01/30/2017 10-K/A Annual Report for the period ended September 30, 2016 [amend]
12/30/2016 4 McManus John L (President and CEO) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.
Txns: Granted 25,000 shares @ $0.15, valued at $3.8k
Granted 250,000 options to buy @ $0.1855, valued at $46.4k
12/20/2016 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
12/20/2016 10-K Annual Report for the period ended September 30, 2016
09/13/2016 8-K Form 8-K - Current report
08/15/2016 10-Q Quarterly Report for the period ended June 30, 2016
05/26/2016 8-K Form 8-K - Current report
05/16/2016 10-Q/A Quarterly Report for the period ended March 31, 2016 [amend]
05/13/2016 10-Q Quarterly Report for the period ended March 31, 2016
04/19/2016 DEF 14C Form DEF 14C - Other definitive information statements:
03/23/2016 PRE 14C Form PRE 14C - Other preliminary information statements
02/23/2016 8-K Form 8-K - Current report
02/16/2016 10-Q Quarterly Report for the period ended December 31, 2015
02/16/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2016 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933 [Amend]
02/08/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
02/03/2016 4 KUMAR AMIT (Director) has filed a Form 4 on AEOLUS PHARMACEUTICALS, INC.
Txns: Granted 100,000 options to buy @ $0.2612, valued at $26.1k
Granted 100,000 options to buy @ $0.24, valued at $24k
Granted 100,000 options to buy @ $0.25, valued at $25k
01/26/2016 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933
12/18/2015 10-K Annual Report for the period ended December 14, 2015
12/15/2015 8-K Form 8-K - Current report
12/15/2015 8-K/A Form 8-K/A - Current report [Amend]
10/05/2015 8-K Form 8-K - Current report
08/14/2015 10-Q Quarterly Report for the period ended June 30, 2015
05/15/2015 10-Q Quarterly Report for the period ended March 31, 2015
05/04/2015 8-K Form 8-K - Current report
02/17/2015 SC 13G/A BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in Aeolus Pharmaceuticals, Inc.
02/13/2015 10-Q Quarterly Report for the period ended December 31, 2014
02/13/2015 10-K/A Annual Report for the period ended September 30, 2014 [amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy